ABSTRACT
Purpose: To present a case of tattoo side effects not limited to the tattoo site and rise an alarm regarding using non-FDA-approved products. Observations: A 30-year-old female presented with bilateral ocular pain, dryness, and itching. The ocular exam showed bilateral injection and edema of the superior palpebral and bulbar conjunctiva. Several 1-2 mm dark pigmented lesions and papillae coursing along the upper palpebral conjunctival lid margin and 5 mm above the margin were found in both eyes. The ocular surface was dry with diffuse superficial punctate keratitis. The biopsy report showed granular foreign material in the dermis. SOX-10 and MART-1 immunostaining highlighted melanocyte distribution and the sample was diagnosed as exogenous pigment consistent with tattoo ink by the pathologist. On further investigation following the pathology report, the patient stated that she got bilateral permanent eyebrow tattoos 4 months before presentation in a country other than the United States, and she was not aware about the standards of the ink used, nor the certification of the person performing the tattoo. The patient denied any type of tattoo or manipulation on the eyes or orbit, including sclera or conjunctivae. Conclusions: Importance: The complications of periorbital tattooing are not limited to the point tattoo location and can potentially spread to the nearby segments. It is notable that there is no FDA approved tattoo ink available, even with a certified tattoo artist performing the tattoo, the risks of inflammation, infection, and other side effects are still present.
ABSTRACT
PURPOSE: To study the effect of peripheral iridectomy (PI) in phacotrabeculectomy. SETTING: Academic private glaucoma practice with a primarily white patient population. METHODS: This retrospective study comprised 126 eyes of 117 patients randomized for PI or no PI during phacotrabeculectomy who were followed for 12 months. Postoperative parameters in both groups included intraocular pressure (IOP), bleb development, visual acuity, and complications. RESULTS: There were no statistically significant differences between the 2 groups in visual acuity or IOP. Bleb development required significantly more 5-fluorouracil therapy in the no-PI group than in the PI group; however, bleb failure and the need for laser suture lysis were not significantly different between groups. Complications were rare in both groups. CONCLUSION: Phacotrabeculectomy without PI may be an acceptable alternative to the surgical management of co-existing cataract and glaucoma.
